eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 04/01/2012
PIL Asasantin Retard

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/01/2012 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/12/2011 and displayed until 04/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 01/07/2010 and displayed until 13/12/2011
Reasons for adding or updating:
  • Change to storage instructions
Updated on 05/08/2009 and displayed until 01/07/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 03/07/2009 and displayed until 05/08/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/07/2009 and displayed until 03/07/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 15/12/2008 and displayed until 02/07/2009
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 21/03/2007 and displayed until 15/12/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 11/05/2006 and displayed until 21/03/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 18/02/2003 and displayed until 11/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 06/03/2001 and displayed until 18/02/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   aspirin
   dipyridamole